Evening Standard | Intu taps the market to fund £870m Westfield malls deal Evening Standard GlaxoSmithKline had bad news for investors, revealing that the third phase of its MAGE-A3 lung cancer treatment has not gone as hoped. The drug giant said it was pushing ahead with trials to see if the treatment ... Electronic parts provider Premier ... |
